Altered excitability and exocytosis in chromaffin cells from the R6/1 mouse model of Huntington's disease is linked to over‐expression of mutated huntingtin
- 5 September 2018
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 147 (4) , 454-476
Abstract
As the peripheral sympathoadrenal axis is tightly controlled by the cortex via hypothalamus and brain stem, the central pathological features of Hunting's disease, (HD) that is, deposition of mutated huntingtin and synaptic dysfunctions, could also be expressed in adrenal chromaffin cells. To test this hypothesis we here present a thorough investigation on the pathological and functional changes undergone by chromaffin cells (CCs) from 2‐month (2 m) to 7‐month (7 m) aged wild‐type (WT) and R6/1 mouse model of Huntington's disease (HD), stimulated with acetylcholine (ACh) or high [K+] (K+). In order to do this, we used different techniques such as inmunohistochemistry, patch‐clamp, and amperometric recording. With respect to WT cells, some of the changes next summarized were already observed in HD mice at a pre‐disease stage (2 m); however, they were more pronounced at 7 m when motor deficits were clearly established, as follows: (i) huntingtin over‐expression as nuclear aggregates in CCs; (ii) smaller CC size with decreased dopamine β‐hydroxylase expression, indicating lesser number of chromaffin secretory vesicles; (iii) reduced adrenal tissue catecholamine content; (iv) reduced Na+ currents with (v) membrane hyperpolarization and reduced ACh‐evoked action potentials; (v) reduced [Ca2+]c transients with faster Ca2+ clearance; (vi) diminished quantal secretion with smaller vesicle quantal size; (vii) faster kinetics of the exocytotic fusion pore, pore expansion, and closure. On the basis of these data, the hypothesis is here raised in the sense that nuclear deposition of mutated huntingtin in adrenal CCs of R6/1 mice could be primarily responsible for poorer Na+ channel expression and function, giving rise to profound depression of cell excitability, altered Ca2+ handling and exocytosis.Open Practices: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/. image Cover Image for this issue: doi: 10.1111/jnc.14201.Keywords
Funding Information
- Horizon 2020 (766124)
- Ministerio de Economía y Competitividad (2016-78892-R)
This publication has 35 references indexed in Scilit:
- Smaller quantal size and faster kinetics of single exocytotic events in chromaffin cells from the APP/PS1 mouse model of Alzheimer’s diseaseBiochemical and Biophysical Research Communications, 2012
- Increased Neurotransmitter Release at the Neuromuscular Junction in a Mouse Model of Polyglutamine DiseaseThe Journal of Neuroscience, 2011
- Formation of Polyglutamine Inclusions in a Wide Range of Non-CNS Tissues in the HdhQ150 Knock-In Mouse Model of Huntington's DiseasePLOS ONE, 2009
- Impaired Glucose Tolerance in the R6/1 Transgenic Mouse Model of Huntington’s DiseaseJournal of Neuroendocrinology, 2007
- Catecholamine exocytosis is diminished in R6/2 Huntington’s disease model miceJournal of Neurochemistry, 2007
- Immunohistochemical Localization of Huntingtin-associated Protein 1 in Endocrine System of the RatJournal of Histochemistry & Cytochemistry, 2005
- Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic MiceNeurobiology of Disease, 2001
- Expression of Huntingtin-Associated Protein-1 in Neuronal Cells Implicates a Role in Neuritic GrowthMolecular and Cellular Neuroscience, 2000
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- A huntingtin-associated protein enriched in brain with implications for pathologyNature, 1995